Andrew Singleton: Advancing Neurogenetics and Dementia Research
The fight against neurodegenerative diseases requires a deep understanding of the genetic blueprints that govern brain health. Andrew Singleton, a distinguished British neurogeneticist, has dedicated his career to uncovering the molecular drivers behind some of the most challenging conditions affecting the human mind, including Parkinson's disease and various forms of dementia.
Key Facts
- Specialization: Neurogenetics and neuroscience.
- Current Role: Director of the Center for Alzheimer's and Related Dementias (CARD) at the NIA.
- Key Research Areas: Parkinson's disease, ataxia, dystonia, and Alzheimer's disease.
- Notable Affiliations: National Institutes of Health (NIH) and Mayo Clinic.
Academic Foundation and Early Career
Born in 1972 in Guernsey, the Channel Islands, Andrew Singleton's journey into science began with a strong academic foundation at the Guernsey Grammar School. He pursued higher education in the United Kingdom, earning a first-class degree in Applied Physiology from Sunderland University.
Singleton further specialized by obtaining a PhD in neuroscience from the University of Newcastle upon Tyne. During his doctoral studies, he worked at the Medical Research Council (MRC) Neurochemical Pathology Unit, where he focused on the genetics of Alzheimer's disease and other forms of dementia—conditions characterized by the progressive loss of cognitive function.
Professional Evolution in the United States
In 1999, Singleton transitioned his research to the United States, joining the Mayo Clinic in Jacksonville, Florida. Here, he expanded his expertise by studying the genetic basis of Parkinson's disease, ataxia (a lack of muscle coordination), and dystonia (a movement disorder characterized by involuntary muscle contractions).
[no image available]
His career progressed rapidly within the federal research system. In 2001, he joined the National Institutes of Health (NIH) to lead the Molecular Genetics unit within the Laboratory of Neurogenetics. By 2006, he was appointed Chief of the Laboratory of Neurogenetics, a role that allowed him to steer critical research into the hereditary nature of brain disorders.
Leadership at the National Institute on Aging (NIA)
Singleton's contributions were formally recognized in 2017 when he became an NIH Distinguished Investigator within the intramural program at the National Institute on Aging (NIA). His leadership trajectory culminated in 2020 when he stepped down as Chief of the Laboratory of Neurogenetics to serve as the Acting Director of the newly established Center for Alzheimer's and Related Dementias (CARD). In 2021, he officially assumed the role of Director of CARD.
Career Summary
| Period/Year | Institution/Role | Focus Area |
|---|---|---|
| PhD Years | University of Newcastle upon Tyne / MRC | Alzheimer's and Dementias |
| 1999 | Mayo Clinic, Florida | Parkinson's, Ataxia, and Dystonia |
| 2001 | NIH, Molecular Genetics Unit | Neurogenetics |
| 2006 | Chief, Laboratory of Neurogenetics | Neurogenetics Leadership |
| 2017 | NIH Distinguished Investigator | NIA Intramural Program |
| 2021 | Director of CARD | Alzheimer's and Related Dementias |
Frequently Asked Questions
What is Andrew Singleton's primary field of study?
Andrew Singleton is a neurogeneticist specializing in neuroscience, with a particular focus on the genetic causes of neurodegenerative diseases.
Which diseases has Andrew Singleton researched?
His research has covered a wide spectrum of neurological conditions, including Parkinson's disease, Alzheimer's disease, other forms of dementia, ataxia, and dystonia.
What is CARD and what is Singleton's role there?
CARD stands for the Center for Alzheimer's and Related Dementias at the National Institute on Aging (NIA). Andrew Singleton currently serves as the Director of this center.
Where did Andrew Singleton receive his PhD?
He earned his PhD in neuroscience from the University of Newcastle upon Tyne, where he conducted research at the Medical Research Council (MRC) Neurochemical Pathology Unit.
When did Andrew Singleton move to the United States?
He moved to the United States in 1999 to begin working at the Mayo Clinic in Jacksonville, Florida.